
Longevity Vision Fund
North America, New York, United States, New York
Description
Longevity Vision Fund invests in technologies that have the potential to disrupt life sciences and extend healthy lifespan.
Investor Profile
Longevity Vision Fund has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 5% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, Hong Kong, Isle of Man.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (53%)
- Series C (26%)
- Series A (11%)
- Convertible Note (5%)
- Debt Financing (5%)
Country Focus
- United States (84%)
- Hong Kong (11%)
- Isle of Man (5%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Medical Device
- Life Science
- Biopharma
- Genetics
- Therapeutics
- Health Diagnostics
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.